Differential proinflammatory and angiogenesis-specific cytokine production in human pulmonary endothelial cells, HPMEC-ST1.6R infected with dengue-2 and dengue-3 virus

Journal of Virological Methods

Volumn 138, Issue 1-2, 2006, Pages 211-217

  Azizan, Azliyati ^a,b   Sweat, James ^b   Espino, Carlos ^a   Gemmer, Jennifer ^b   Stark, Lillian ^a,b   Kazanis, Deno ^b  

^a NATIONAL SCHOOL OF PUBLIC HEALTH   (United States)

^b FLORIDA DEPARTMENT OF HEALTH   (United States)

Author keywords

Angiogenesis; Cytokines; Dengue; Dengue hemorrhagic fever; Endothelial cells; Microbead bioplex

Indexed keywords

ANGIOGENIC PROTEIN; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CELL FUNCTION; CYTOKINE PRODUCTION; CYTOPATHOGENIC EFFECT; CYTOPLASM; DENGUE; DENGUE VIRUS; DOT HYBRIDIZATION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOASSAY; IMMUNOFLUORESCENCE; LUNG ENDOTHELIUM; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROTYPE; TH1 CELL; TH2 CELL; VIRUS INFECTION; VIRUS STRAIN;

CELL LINE; CYTOKINES; CYTOPATHOGENIC EFFECT, VIRAL; DENGUE VIRUS; ENDOTHELIAL CELLS; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOBLOTTING; LUNG; MICROSPHERES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VIRAL PROTEINS;

DENGUE VIRUS; DENGUE VIRUS TYPE 3;

EID: 33750357043     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2006.08.010     Document Type: Article

References (31)

1. Avila-Aguero M.L., Avila-Aguero C.R., Um S.L., Soriano-Fallas A., Canas-Coto A., and Yan S.B. Systemic host inflammatory and coagulation response in the Dengue virus primo-infection. Cytokine 27 6 (2004) 173-179
2. Avirutnan P., Malasit P., Seliger B., Bhakdi S., and Husmann M. Dengue virus infection of human endothelial cells leads to chemokine production, complement activation, and apoptosis. J. Immunol. 161 11 (1998) 6338-6346
3. Bosch I., Xhaja K., Estevez L., Raines G., Melichar H., Warke R.V., Fournier M.V., Ennis F.A., and Rothman A.L. Increased production of interleukin-8 in primary human monocytes and in human epithelial and endothelial cell lines after dengue virus challenge. J. Virol. 76 11 (2002) 5588-5597
4. Chang G.J., Hunt A.R., Holmes D.A., Springfield T., Chiueh T.S., Roehrig J.T., and Gubler D.J. Enhancing biosynthesis and secretion of premembrane and envelope proteins by the chimeric plasmid of dengue virus type 2 and Japanese encephalitis virus. Virology 306 1 (2003) 170-180
5. de Jager W.C., Velthuis H., Prakken B.J., Kuis W., and Rijkers G.T. Simultaneous Detection of 15 human cytokines in a single sample of stimulated peripheral mononuclear cells. Clin. Diagn. Lab. Immunol. 10 1 (2003) 133-139
6. Fernandez-Mestre M.T., Gendzekhadze K., Rivas-Vetencourt P., and Layrisse Z. TNF-alpha-308A allele, a possible severity risk factor of hemorrhagic manifestation in dengue fever patients. Tissue Antigens 64 4 (2004) 469-472
7. Gagnon S.J., Leporati A., Green S., Kalayanarooj S., Vaughn D.W., Stephens H.A., Suntayakorn S., Kurane I., Ennis F.A., and Rothman A.L. T cell receptor Vbeta gene usage in Thai children with dengue virus infection. Am. J. Trop. Med. Hyg. 64 1-2 (2001) 41-48
8. Halstead S.B. More dengue, more questions. Emerg. Infect. Dis. 11 5 (2005) 740-741
9. Huang Y.H., Lei H.Y., Liu H.S., Lin Y.S., Liu C.C., and Yeh T.M. Dengue virus infects human endothelial cells and induces IL-6 and IL-8 production. Am. J. Trop. Med. Hyg. 63 1-2 (2000) 71-75
10. Johnson A.J., Noga A.J., Kosoy O., Lanciotti R.S., Johnson A.A., and Biggerstaff B.J. Duplex microsphere-based immunoassay for detection of anti-West Nile virus and anti-St. Louis encephalitis virus immunoglobulin m antibodies. Clin. Diagn. Lab. Immunol. 12 5 (2005) 566-574
11. Krump-Konvalinkova V., Bittinger F., Unger R.E., Peters K., Lehr H.A., and Kirkpatrick C.J. Generation of human pulmonary microvascular endothelial cell lines. Lab. Invest. 81 12 (2001) 1717-1727
12. Kurane I., and Takasaki T. Dengue fever and dengue haemorrhagic fever: challenges of controlling an enemy still at large. Rev. Med. Virol. 11 5 (2001) 301-311
13. Malavige G.N., Fernando S., Fernando D.J., and Seneviratne S.L. Dengue viral infections. Postgrad. Med. J. 80 948 (2004) 588-601
14. Medin C.L., Fitzgerald K.A., and Rothman A.L. Dengue virus nonstructural protein NS5 induces interleukin-8 transcription and secretion. J. Virol. 79 17 (2005) 11053-11061
15. Nguyen T.H., Lei H.Y., Nguyen T.L., Lin Y.S., Huang K.J., Le B.L., Lin C.F., Yeh T.M., Do Q.H., Vu T.Q., Chen L.C., Huang J.H., Lam T.M., Liu C.C., and Halstead S.B. Dengue hemorrhagic fever in infants: a study of clinical and cytokine profiles. J. Infect. Dis. 189 2 (2004) 221-232
16. Porter J.F., Sharma S., Wilson D.L., Kappil M.A., Hart R.P., and Denhardt D.T. Tissue inhibitor of metalloproteinases-1 stimulates gene expression in MDA-MB-435 human breast cancer cells by means of its ability to inhibit metalloproteinases. Breast Cancer Res. Treat. 94 2 (2005) 185-193
17. Raviprakash K., Ewing D., Simmons M., Porter K.R., Jones T.R., Hayes C.G., Stout R., and Murphy G.S. Needle-free Biojector injection of a dengue virus type 1 DNA vaccine with human immunostimulatory sequences and the GM-CSF gene increases immunogenicity and protection from virus challenge in Aotus monkeys. Virology 315 2 (2003) 345-352
18. Raviprakash K., Marques E., Ewing D., Lu Y., Phillips I., Porter K.R., Kochel T.J., August T.J., Hayes C.G., and Murphy G.S. Synergistic neutralizing antibody response to a dengue virus type 2 DNA vaccine by incorporation of lysosome-associated membrane protein sequences and use of plasmid expressing GM-CSF. Virology 290 1 (2001) 74-82
19. Rothman A.L. Immunology and immunopathogenesis of dengue disease. Adv. Virus Res. 60 (2003) 397-419
20. Rothman A.L. Dengue: defining protective versus pathologic immunity. J. Clin. Invest. 113 7 (2004) 946-951
21. Rothman A.L., and Ennis F.A. Immunopathogenesis of Dengue hemorrhagic fever. Virology 257 1 (1999) 1-6
22. Shu P.Y., Chang S.F., Kuo Y.C., Yueh Y.Y., Chien L.J., Sue C.L., Lin T.H., and Huang J.H. Development of group- and serotype-specific one-step SYBR green I-based real-time reverse transcription-PCR assay for dengue virus. J. Clin. Microbiol. 41 6 (2003) 2408-2416
23. Solomon T., and Mallewa M. Dengue and other emerging flaviviruses. J. Infect. 42 2 (2001) 104-115
24. Suharti C., van Gorp E.C., Dolmans W.M., Setiati T.E., Hack C.E., Djokomoeljanto R., and van der Meer J.W. Cytokine patterns during dengue shock syndrome. Eur. Cytokine Netw. 14 3 (2003) 172-177
25. Suharti C., van Gorp E.C., Setiati T.E., Dolmans W.M., Djokomoeljanto R.J., Hack C.E., ten C.H., and van der Meer J.W. The role of cytokines in activation of coagulation and fibrinolysis in dengue shock syndrome. Thromb. Haemost. 87 1 (2002) 42-46
26. Talavera D., Castillo A.M., Dominguez M.C., Gutierrez A.E., and Meza I. IL8 release, tight junction and cytoskeleton dynamic reorganization conducive to permeability increase are induced by dengue virus infection of microvascular endothelial monolayers. J. Gen. Virol. 85 Pt 7 (2004) 1801-1813
27. Tseng C.S., Lo H.W., Teng H.C., Lo W.C., and Ker C.G. Elevated levels of plasma VEGF in patients with dengue hemorrhagic fever. FEMS Immunol. Med. Microbiol. 43 1 (2005) 99-102
28. Udani V.M., Santarelli J.G., Yung Y.C., Wagers A.J., Cheshier S.H., Weissman I.L., and Tse V. Hematopoietic stem cells give rise to perivascular endothelial-like cells during brain tumor angiogenesis. Stem Cells Dev. 14 5 (2005) 478-486
29. Unger R.E., Krump-Konvalinkova V., Peters K., and Kirkpatrick C.J. In vitro expression of the endothelial phenotype: comparative study of primary isolated cells and cell lines, including the novel cell line HPMEC-ST1.6R. Microvasc. Res. 64 3 (2002) 384-397
30. Xiao D., Tan W., Li M., and Ding J. Antiangiogenic potential of 10-hydroxycamptothecin. Life Sci. 69 14 (2001) 1619-1628
31. Zhao L., Wang K., Ferrara N., and Vu T.H. Vascular endothelial growth factor co-ordinates proper development of lung epithelium and vasculature. Mech. Dev. 122 7-8 (2005) 877-886